|
|
Article: The Immune Response Corporation Announces Study Suggesting Protection From HIV Infection and Induction of HIV-Specific Immune Responses Using REMUNE(R) Antigen With CpG ODN.
- Article from:
- PR Newswire
- Article date:
- October 17, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Findings Published in Journal of Infectious Diseases Shows Genital and Vaginal HIV-Specific Immune Responses Resulting From Innovative Intranasal Immunization
The Immune Response Corporation announced today the final results of a study at McMaster University Health Sciences Centre suggesting that use of REMUNE(R) antigen in combination with oligonucleotides containing immunostimulatory CpG motifs (CpG ODN) induces HIV-specific immune responses in genital and vaginal tracts and protected animals from infection after virus challenge. The study, which was the subject of a previous Company press release, was designed to ascertain if this approach might be an ...